Riverstone Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,578
Closed -$564K 54
2023
Q1
$564K Sell
20,578
-1,991
-9% -$55.4K 0.36% 31
2022
Q4
$631K Sell
22,569
-11,203
-33% -$338K 0.44% 27
2022
Q3
$996K Sell
33,772
-2,532
-7% -$79.4K 0.64% 25
2022
Q2
$1.02M Sell
36,304
-37
-0.1% -$1.05K 0.64% 24
2022
Q1
$1.13M Sell
36,341
-21,885
-38% -$645K 0.58% 22
2021
Q4
$1.72M Sell
58,226
-27,186
-32% -$794K 0.76% 20
2021
Q3
$2.56M Sell
85,412
-10,966
-11% -$377K 1.18% 18
2021
Q2
$3.5M Sell
96,378
-1,875
-2% -$69.6K 1.66% 18
2021
Q1
$3.6M Sell
98,253
-2,814
-3% -$104K 1.88% 16
2020
Q4
$3.67M Sell
101,067
-8,772
-8% -$297K 2.04% 15
2020
Q3
$3.29M Sell
109,839
-481
-0.4% -$15K 2.19% 14
2020
Q2
$3.28M Buy
110,320
+205
+0.2% +$6.07K 2.44% 12
2020
Q1
$2.92M Buy
110,115
+707
+0.6% +$26.8K 2.96% 11
2019
Q4
$4.63M Sell
109,408
-49
-0% -$2.07K 3.46% 10
2019
Q3
$4.57M Buy
109,457
+2,851
+3% +$111K 3.51% 9
2019
Q2
$3.92M Sell
106,606
-118
-0.1% -$4.3K 3.06% 10
2019
Q1
$4.07M Sell
106,724
-5,520
-5% -$205K 3.42% 8
2018
Q4
$3.94M Buy
+112,244
New +$3.89M 3.94% 8

Other funds holding OHI

Riverstone Advisors's OHI Position: Q2 2023 in Review

Riverstone Advisors sold out of Omega Healthcare (OHI) in Q2 2023, closing a stake of 20,578 shares — an estimated $564K sold.

Riverstone Advisors first reported a position in OHI in Q4 2018 and held it in 18 quarters. The position peaked at $4.63M in Q4 2019. 511 funds tracked by Wall St. Rank hold OHI as of Q2 2023.

  • Riverstone Advisors reported no remaining Omega Healthcare position as of Q2 2023 after selling out during the quarter.
  • Riverstone Advisors sold 20,578 Omega Healthcare shares in Q2 2023, an estimated $564K.
  • Riverstone Advisors first reported a position in Omega Healthcare in Q4 2018 and held it in 18 quarters.
  • Riverstone Advisors's Omega Healthcare position peaked at $4.63M in Q4 2019.
  • 511 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2023.

Based on Riverstone Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.